News
Fighting Blindness Canada is urging Johnson & Johnson to continue pursuing regulatory approval for botaretigene sparoparvovec (bota-vec), a gene therapy for X-linked retinitis pigmentosa (XLRP). This potential treatment has offered new hope…
Read More about FBC Supports Path Forward for XLRP Treatment
As one of Fighting Blindness Canada’s 2024 Research Grant Awardees, Dr. Liu is leading an ambitious project focused on congenital stationary night blindness type 2A (CSNB2A)—a rare inherited retinal disease that causes…
Read More about Dr. Baohua Liu: Shining a Light on the Visual Cortex
When Alexis Nickerson’s son, Harry, was nine years old, everything changed in an instant. Harry, a talented gymnast since the age of two, ran straight into an bar. At first, it seemed…
Read More about Alexis Nickerson: Fostering Resilience
Dagmar Jamieson has a remarkable story to tell. At age 13, she was diagnosed with a debilitating eye disease resembling macular degeneration, making it increasingly difficult to see, and the pressures of…
Read More about Living Life to the Fullest
Dr. Brittany Carr, University of Alberta, who was recently awarded a $200,000 Early Career Research Grant from Fighting Blindness Canada, is diving deep into the mysteries of photoreceptors—specialized cells that allow us…
Read More about Dr. Brittany Carr: Innovating & Creating New Treatments
By Jennifer Jones, President and CEO, Fighting Blindness Canada The uncertainty surrounding tariffs and research funding cuts in the United States is sending shockwaves through the global scientific community. The U.S. has…
Read More about Protecting Vision Research in the Face of Potential U.S. CutbacksJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
